Vigil Neuroscience, Inc.
VIGLDelisted Aug 5, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827087
Vigil Neuroscience, Inc. was delisted on Aug 5, 2025; its insiders filed their last Form 4 on Aug 7, 2025; 78 institutions reported holding it in 13F filings for Q2 2025, worth $265.8M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Vigil Neuroscience, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 47 | 45 | −2 |
| Shares | 25.8M | 25.5M | −207.5K (−0.8%) |
| Value | $242.1M | $137.7M | −$104.4M (−43.1%) |
New holders (2)
Institutions that held Vigil Neuroscience, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ensign Peak Advisors, Inc | 11,924 | $64.3K | 0.00% |
| Nisa Investment Advisors, LLC | 30 | $162 | 0.00% |
Sold out (4)
Institutions that held Vigil Neuroscience, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Bank of Montreal | 73,243 | $728.0K |
| MetLife Investment Management | 9,105 | $85.6K |
| Metropolitan Life Insurance Co | 944 | $8.87K |
| State of Wyoming | 143 | $1.34K |